SOSV

What is SOSV?

SOSV is a global venture capital firm that invests across multiple stages with a deep focus on deep tech for human and planetary health, aiming for a radically beneficial impact. With headquarters in Princeton, New Jersey, and founded in 1994, SOSV has become a prominent VC, known for its accelerator-based approach.

The firm invests in a wide variety of sectors including software, education, biotech, agrotech, fintech, hardware, energy, retail, IoT, cleantech, AI, healthtech, blockchain, food & beverage, impact, and more.

Their investment stages include pre-seed, seed, early-stage, Series A, and Series B, with a specialty in supporting pre-seed deep tech companies. SOSV's investment size ranges from a minimum of $100,000 to a maximum of $2,000,000, with a sweet spot around $1,000,000. Its assets under management total approximately $1.2 billion.

Through their startup development programs, IndieBio and HAX, SOSV facilitates the growth of deep tech startups in fields such as synthetic biology, therapeutics, food innovation, and material science among others. They provide robust laboratory and office spaces for founders to develop their prototypes and access sophisticated equipment. With over 1,000 co-investors in their network, SOSV actively participates in follow-on funding rounds and propels their deep tech portfolio to raise significant capital post-program.

The firm champions diversity among its founders and teams, who represent numerous nationalities and educational backgrounds, with many holding PhDs. SOSV curates events and summits to drive the climate and health tech ecosystems, reinforcing its dedication to human and planetary health throughout the lifetime of its investments.

What they say:

SOSV is the most active deep tech venture capital firm globally, investing at pre-seed (or at startup inception) supporting visionary founders intent on making a profound impact on human and planetary health. SOSV has three deeply resourced locations for founders in San Francisco (SOSV SF), New York (SOSV NY), and Newark (SOSV HAX). Each year, SOSV makes roughly 60 pre-seed investments of up to $550K each, as well as another 150 follow-on investments in deep tech companies. The pre-seed founders spend 4–6 months working side-by-side with SOSV General Partners and the broader team of experts in science and engineering, design and product development, supply chain and product-market fit. Additionally, founders gain access to each location’s office space and equipped lab space.

What we look for: We invest in pre-seed deep tech companies through one of our accelerators. Life sciences (synthetic biology, syn bio, healthcare, climate tech, clean tech, therapeutics, drug, food, cell cultured meats, biomanufacturing, neuroscience, etc.)

How we help: A venture-building accelerator providing advanced lab facilities, hands-on support from scientific and engineering experts, software and cloud credits, investor access, follow-on funding opportunities, and specialized mentorship in product development, regulatory compliance, and commercialization.